Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoproliferative Disorder Following Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT03128034
What this trial is testing

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia+9 more
Fred Hutchinson Cancer Center 75
Testing effectiveness (Phase 2)Study completedNCT02405364
What this trial is testing

Front-line Therapy With Carfilzomib, Lenalidomide, and Dexamethasone Induction

Who this might be right for
Multiple Myeloma
University Hospital, Toulouse 46
Testing effectiveness (Phase 2)Study completedNCT01919619
What this trial is testing

Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies

Who this might be right for
B-Cell Non-Hodgkin LymphomaHematopoietic and Lymphoid Cell NeoplasmLeukemia+3 more
M.D. Anderson Cancer Center 41
Testing effectiveness (Phase 2)Study completedNCT00309907
What this trial is testing

Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChildhood Acute Lymphoblastic Leukemia in Remission+22 more
Children's Oncology Group 39
Testing effectiveness (Phase 2)Ended earlyNCT03622775
What this trial is testing

Daratumumab in Treating Participants With Relapsed Multiple Myeloma After Stem Cell Transplant

Who this might be right for
Recurrent Plasma Cell Myeloma
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)UnknownNCT03669445
What this trial is testing

Study Association of Lenalidomide, Ixazomib, Dexamethasone and Daratumumab in Newly Diagnosed Standard Risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Hospital, Toulouse 45
Testing effectiveness (Phase 2)Study completedNCT04099901
What this trial is testing

Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial

Who this might be right for
Multiple Myeloma
Radboud University Medical Center 88
Large-scale testing (Phase 3)Study completedNCT01100502
What this trial is testing

Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial)

Who this might be right for
Disease, Hodgkin
Seagen Inc. 329
Not applicableStudy completedNCT03546101
What this trial is testing

Early Detection of Epstein-Barr Virus Related Disease.

Who this might be right for
Post-transplant Lymphoproliferative DisorderMononucleosisEpstein-Barr Virus Infections+6 more
University of Aarhus 1,527
Large-scale testing (Phase 3)Study completedNCT00053053
What this trial is testing

Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer

Who this might be right for
CachexiaLymphomaLymphoproliferative Disorder+1 more
Radiation Therapy Oncology Group 472
Testing effectiveness (Phase 2)UnknownNCT01849939
What this trial is testing

Eradication of Residual Disease by Preemptive Immunointervention After Allogeneic Hematopoietic Stem Cells Transplantation in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaLymphocytic Lymphoma
University Hospital, Clermont-Ferrand 43
Testing effectiveness (Phase 2)UnknownNCT05493800
What this trial is testing

Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT

Who this might be right for
Oral MucositisLymphomaMultiple Myeloma+1 more
MitoImmune Therapeutics 60
Large-scale testing (Phase 3)Looking for participantsNCT04566328
What this trial is testing

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Who this might be right for
Plasma Cell MyelomaRISS Stage I Plasma Cell MyelomaRISS Stage II Plasma Cell Myeloma
ECOG-ACRIN Cancer Research Group 1,450
Early research (Phase 1)Ended earlyNCT00672152
What this trial is testing

A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Transplantation

Who this might be right for
Acute Myelogenous Leukemia (AML)Chronic Myelogenous Leukemia (CML)Acute Lymphoblastic Leukemia (ALL)+2 more
Michael Morse, MD 8
Early research (Phase 1)Study completedNCT00006040
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00006478
What this trial is testing

Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Nebraska 19
Testing effectiveness (Phase 2)Study completedNCT01008462
What this trial is testing

Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Who this might be right for
B-Cell Prolymphocytic LeukemiaHypodiploidyLoss of Chromosome 17p+18 more
Fred Hutchinson Cancer Center 16
Not applicableUnknownNCT01555359
What this trial is testing

Telomerase Activity as a Marker For Mobilization Quality

Who this might be right for
LymphomaMultiple Myeloma
Rabin Medical Center 50
Early research (Phase 1)Study completedNCT00561418
What this trial is testing

Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma

Who this might be right for
LymphomaSmall Intestine Cancer
Ohio State University Comprehensive Cancer Center 23
Testing effectiveness (Phase 2)Looking for participantsNCT06928662
What this trial is testing

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Who this might be right for
Acute Myeloid LeukemiaAcute Undifferentiated LeukemiaMixed Phenotype Acute Leukemia+11 more
Fred Hutchinson Cancer Center 36
Next Page